• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance

cafead

Administrator
Staff member
  • cafead   Jul 29, 2021 at 11:22: AM
via Eli Lilly is beginning a research alliance discovering and developing small molecules that stimulate immune responses against cancer. If drugs from the partnership reach the market, Kumquat could earn up to $2 billion in milestone payments.

article source
 

<